Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

Clinical trial NCT03672851 · TERMINATED

Trial details

NCT number: NCT03672851
Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemia Acute Leukemia in Relapse Acute Myeloid Leukemia Relapsed or Refractory Acute Leukemia

Start date: 2019-04-17
Primary completion: 2019-07-31
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.